Phase 1/2 clinical trial - Business-News-Today.com

🧬 Interested in pharma, biotech and medical device news? Visit PharmaDeviceNews.com →

Business news, market intelligence, and global industry analysis.

The Latest

A smart-glasses engineering workspace reflects Magic Leap’s 269 planned job cuts as the augmented reality pioneer exits first-party devices and pivots towards supplying waveguides and optical technology for artificial intelligence glasses. Representative image.

Magic Leap layoffs rise to 269 as augmented reality pioneer abandons first-party devices

Representative image showing large-scale iron ore mining operations, reflecting investor focus on Rio Tinto plc’s capital intensity, iron ore margins, and balance-sheet pressures following its 2025 results and share price decline.

Fortescue (ASX: FMG) shares fall as $525m Iron Bridge impairment overshadows record shipments

CBIZ to be taken private by Grant Thornton in largest US accounting M&A in 25+ years

Saudi Arabia unveils 14-country maritime coalition to protect Red Sea shipping

New Hope for Colorectal Cancer Patients: Regeneron Pharmaceuticals’ Immunotherapy Trial Yields Early Success

Read More

Pharma Industry News

Breakthrough in colorectal cancer as Regeneron Pharmaceuticals reveals promising results from immunotherapy trial

Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) has announced encouraging early outcomes from its Phase 1/2 clinical trial, which evaluates…

byPallavi Madhiraju

May 25, 2024

web analytics